Citizens Financial Group Inc RI Has $103,000 Stake in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Citizens Financial Group Inc RI boosted its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 34.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,260 shares of the pharmacy operator’s stock after buying an additional 577 shares during the quarter. Citizens Financial Group Inc RI’s holdings in Walgreens Boots Alliance were worth $103,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Fiera Capital Corp boosted its stake in Walgreens Boots Alliance by 49.3% in the first quarter. Fiera Capital Corp now owns 8,153 shares of the pharmacy operator’s stock worth $373,000 after purchasing an additional 2,692 shares in the last quarter. Moloney Securities Asset Management LLC boosted its stake in Walgreens Boots Alliance by 5.0% in the first quarter. Moloney Securities Asset Management LLC now owns 32,927 shares of the pharmacy operator’s stock worth $1,506,000 after purchasing an additional 1,556 shares in the last quarter. Swiss National Bank boosted its stake in Walgreens Boots Alliance by 21.6% in the first quarter. Swiss National Bank now owns 2,944,392 shares of the pharmacy operator’s stock worth $134,706,000 after purchasing an additional 523,800 shares in the last quarter. Blue Chip Partners Inc. boosted its stake in Walgreens Boots Alliance by 29.0% in the first quarter. Blue Chip Partners Inc. now owns 17,981 shares of the pharmacy operator’s stock worth $823,000 after purchasing an additional 4,043 shares in the last quarter. Finally, Point View Wealth Management Inc. boosted its stake in Walgreens Boots Alliance by 31.9% in the first quarter. Point View Wealth Management Inc. now owns 26,479 shares of the pharmacy operator’s stock worth $1,211,000 after purchasing an additional 6,408 shares in the last quarter. 58.03% of the stock is currently owned by institutional investors and hedge funds.

A number of research firms have commented on WBA. Cowen reduced their price objective on Walgreens Boots Alliance from $54.00 to $48.00 and set a “market perform” rating on the stock in a research note on Tuesday. ValuEngine lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, March 3rd. SunTrust Banks cut their price target on Walgreens Boots Alliance from $58.00 to $42.00 and set a “hold” rating on the stock in a research note on Friday, April 3rd. UBS Group raised Walgreens Boots Alliance from a “sell” rating to a “neutral” rating and cut their price target for the company from $49.00 to $44.00 in a research note on Monday, April 6th. Finally, JPMorgan Chase & Co. cut their price target on Walgreens Boots Alliance from $62.00 to $56.00 and set a “neutral” rating on the stock in a research note on Friday, April 3rd. Four analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $51.21.

NASDAQ WBA opened at $39.60 on Friday. The stock has a 50-day simple moving average of $42.22 and a 200 day simple moving average of $51.33. The company has a market capitalization of $34.87 billion, a PE ratio of 6.87, a P/E/G ratio of 1.83 and a beta of 0.55. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 1.34. Walgreens Boots Alliance Inc has a 12 month low of $36.65 and a 12 month high of $64.50.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, April 2nd. The pharmacy operator reported $1.52 EPS for the quarter, beating analysts’ consensus estimates of $1.46 by $0.06. The business had revenue of $35.82 billion during the quarter, compared to the consensus estimate of $35.24 billion. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The firm’s revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.64 earnings per share. As a group, sell-side analysts predict that Walgreens Boots Alliance Inc will post 5.53 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Wednesday, May 20th will be issued a $0.4575 dividend. The ex-dividend date of this dividend is Tuesday, May 19th. This represents a $1.83 annualized dividend and a dividend yield of 4.62%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 30.55%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: What is a growth and income fund?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.